These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23396042)

  • 21. Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics.
    Davies JR; Liu SM; Acharya KR
    Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30347838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains.
    Davies JR; Rees J; Liu SM; Acharya KR
    J Struct Biol; 2018 May; 202(2):113-117. PubMed ID: 29288126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancing toxin-based vaccines against botulism.
    Przedpelski A; Tepp WH; Zuverink M; Johnson EA; Pellet S; Barbieri JT
    Vaccine; 2018 Feb; 36(6):827-832. PubMed ID: 29307477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of nicking the C-terminal region of the Clostridium botulinum serotype D neurotoxin heavy chain on its toxicity and molecular properties.
    Suzuki T; Kouguchi H; Watanabe T; Hasegawa K; Yoneyama T; Niwa K; Nishikawa A; Lee JC; Oguma K; Ohyama T
    Protein J; 2007 Apr; 26(3):173-81. PubMed ID: 17200883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming the domain structure of botulinum neurotoxins into novel therapeutics.
    Chaddock J
    Curr Top Microbiol Immunol; 2013; 364():287-306. PubMed ID: 23239358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological characterization of the neurotoxin produced by Clostridium botulinum type A associated with infant botulism in Japan.
    Kozaki S; Nakaue S; Kamata Y
    Microbiol Immunol; 1995; 39(10):767-74. PubMed ID: 8577267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the functional activity of botulinum neurotoxin subtype B6.
    Kohda T; Nakamura K; Hosomi K; Torii Y; Kozaki S; Mukamoto M
    Microbiol Immunol; 2017 Nov; 61(11):482-489. PubMed ID: 28898517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Light Chain Diversity among the Botulinum Neurotoxins.
    Gardner AP; Barbieri JT
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30004421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme.
    Ambrin G; Kumar R; Singh BR
    Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endopeptidase activities of botulinum neurotoxin type B complex, holotoxin, and light chain.
    Wang HH; Riding S; Lindo P; Singh BR
    Appl Environ Microbiol; 2010 Oct; 76(19):6658-63. PubMed ID: 20693440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bimodal modulation of the botulinum neurotoxin protein-conducting channel.
    Fischer A; Nakai Y; Eubanks LM; Clancy CM; Tepp WH; Pellett S; Dickerson TJ; Johnson EA; Janda KD; Montal M
    Proc Natl Acad Sci U S A; 2009 Feb; 106(5):1330-5. PubMed ID: 19164566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress in cell based assays for botulinum neurotoxin detection.
    Pellett S
    Curr Top Microbiol Immunol; 2013; 364():257-85. PubMed ID: 23239357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.
    Ayyar BV; Aoki KR; Atassi MZ
    Infect Immun; 2015 Apr; 83(4):1465-76. PubMed ID: 25624352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological and Immunological Characterization of a Functional L-HN Derivative of Botulinum Neurotoxin Serotype F.
    Li Z; Li B; Lu J; Liu X; Tan X; Wang R; Du P; Yu S; Xu Q; Pang X; Yu Y; Yang Z
    Toxins (Basel); 2023 Mar; 15(3):. PubMed ID: 36977091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins.
    Tsukamoto K; Kohda T; Mukamoto M; Takeuchi K; Ihara H; Saito M; Kozaki S
    J Biol Chem; 2005 Oct; 280(42):35164-71. PubMed ID: 16115873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A).
    Kalb SR; Baudys J; Raphael BH; Dykes JK; Lúquez C; Maslanka SE; Barr JR
    Anal Chem; 2015 Apr; 87(7):3911-7. PubMed ID: 25731972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectroscopic analysis of pH-induced changes in the molecular features of type A botulinum neurotoxin light chain.
    Li L; Singh BR
    Biochemistry; 2000 May; 39(21):6466-74. PubMed ID: 10828961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-terminal helix reorients in recombinant C-fragment of Clostridium botulinum type B.
    Jayaraman S; Eswaramoorthy S; Ahmed SA; Smith LA; Swaminathan S
    Biochem Biophys Res Commun; 2005 Apr; 330(1):97-103. PubMed ID: 15781237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of the receptor-binding sites in the carboxyl-terminal half of the heavy chain of botulinum neurotoxin types C and D.
    Tsukamoto K; Kozai Y; Ihara H; Kohda T; Mukamoto M; Tsuji T; Kozaki S
    Microb Pathog; 2008 Jun; 44(6):484-93. PubMed ID: 18242046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity.
    Rummel A
    Curr Top Microbiol Immunol; 2013; 364():61-90. PubMed ID: 23239349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.